for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-EMA Recommendations For June 2018

June 29 (Reuters) - EU Medicines Agency:

* EMA RECOMMENDATIONS FOR JUNE 2018

* EMA RECOMMENDS APPROVAL OF NOVARTIS GENE-BASED CELL THERAPY KYMRIAH

* EMA RECOMMENDS APPROVAL OF BAXALTA’ INNOVATIONS’ DRUG FOR VON WILLEBRAND DISEASE VONICOG ALFA

* EU MEDICINES AGENCY RECOMMENDS APPROVAL OF ULTRAGENYX DRUG FOR TREATMENT OF SLY SYNDROME

* EU MEDICINES AGENCY RECOMMENDS APPROVAL OF GILEAD SCIENCES' CAR-T TREATMENT FOR ADVANCED NON-HODGKIN LYMPHOMA YESCARTA Source text ID: (bit.ly/2Ky9Rwj) Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up